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BACKGROUND
The response of trauma caused by surgery includes 
changes in metabolic, endocrine, and immune 
systems. These changes are caused by afferent 
neuronal stimulus from the area of surgery, cyto-
kines release from tissue damaged by trauma, 
and activation of cellular and humoral immune 
pathways.1,2
Both general and regional anesthesia help to 
suppress the stress response due to surgical trauma. 
This happens because anesthesia provides sympa-
thetic and afferent nerve fibers block that modulate 
the pituitary-adrenocortical system.2,3 Total intra-
venous anesthesia (TIVA) by giving propofol in 
combination with opioids, administrated by TCI 
(target controlled infusion), are currently popular 
in the practice of anesthesia. 
Propofol is the most common drug used for 
TIVA. Some advantages of propofol are rapid onset 
and faster recovery time. The use of TIVA with 
TCI is expected to provide a more constant plasma 
concentration of the drug. To improve its ability to 
cause the triad of anesthesia, some studies use TCI 
propofol in combination with drugs that have the 
synergistic effect, like clonidine or ketamine. 
Clonidine is an alpha-2 agonist often used as a 
premedication due to its various effects, like sedation, 
analgesia, sympatholytic, and may reduce the dose 
of volatile or intravenous anesthetics.3,4 Ketamine is 
a non-competitive  N-methyl-D-aspartate (NMDA) 
antagonist that is used as an induction agent intra-
venously to maintain stable hemodynamics mainly 
due to the sympathomimetic effect. Administration 
of NMDA antagonist and opioid produce the syner-
gistic or additive effect of analgesia. 
The goal of this study is to see if the combina-
tion of TCI propofol plus clonidine and ketamine is 
more effective in reducing the IL-6 level, maintain-
ing intraoperative stability, and reducing postoper-
ative pain and morphine consumption.
PATIENTS AND METHODS
This is a double-blind, randomized, pre and post-
test control group design. Randomization was 
designed by permuted blocks. Ethical clearance 
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ABSTRACT
Background: Propofol is often used in Total Intravenous Anesthesia 
(TIVA). Studies found that adding clonidine and ketamine can increase 
the potential to achieve an adequate level of anesthesia while reducing 
inflammation and post-operative pain. The goal of this study is to see 
if the combination of Target Controlled Infusion (TCI) propofol plus 
clonidine and ketamine is more effective in reducing the IL-6 level, 
maintaining intraoperative stability, and reducing postoperative pain 
and morphine consumption.
Methods: Forty patients planned for major oncology surgery were 
divided into two groups. The treatment group (Group T) received 
pre-medication with clonidine, induction with TCI propofol, and 
intraoperative ketamine. The control group (Group C) received normal 
saline solution. 
Results: The difference of IL-6 level increase between the two groups 
was not statistically significant (13.6 vs. 16.6 pg/mL, p>0.05). Mean 
systolic blood pressure (SBP) and mean arterial pressure (MAP) in 
group T were higher in 5 and 10 minutes after incision, but lower in 
minutes 30, 60, and 120 (p <0.05). Heart rate in group T was higher 
in minutes 5, 10, 15, 30, 60, and 120. Visual analog scale (VAS) in 4, 
8, 12, and 24 hours post-surgery were lower in group T compared to 
group C. And post-operative morphine consumptions in group T were 
also lower. (3.6 ± 1.5 vs 9.9 ± 3.3, p <0.05).
Conclusion: TIVA using TCI propofol combined with preoperative 
clonidine and intraoperative ketamine is effective in maintaining 
hemodynamic stability, reducing post-operative and reducing 
morphine consumption compared to TCI propofol alone. 
Keywords: total intravenous anesthesia, IL-6, hemodynamic stability, visual analog score, morphine consumption
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was given by the Research Ethics Committee of 
Udayana University and Sanglah General Hospital. 
All involved subjects have provided a written 
consent to be included in this study.
This study involved 40 patients with ASA phys-
ical status I and II, aged 16-65 years, who were 
planned for unilateral mastectomy, with surgery 
duration of more than two hours. Those with 
history of cardiac diseases, hemodynamic insta-
bility, chronic pain, and mental disturbance were 
excluded from this study. Subjects were randomly 
divided into two groups by permuted blocks. 
Treatment group (Group T) consists of 20 subjects 
who received intravenous anesthesia with TCI 
propofol combined with clonidine and ketamine, 
and control group (Group C) consists of a similar 
number of subjects who received intravenous anes-
thesia with TCI propofol with placebo (NaCl 0.9%). 
This study involves a third party so that the inter-
vention received by the subjects are not known by 
both researchers and the research subjects. 
After gaining blood sample for preoperative 
IL-6 level, subjects in Group T received premedi-
cation with clonidine 1 mcg/kg in NaCl 0.9% for 
10 minutes. Subjects were then induced using 
propofol TCI plasma mode Schneider target of 
4 mcg/ml. Before intubation, fentanyl 2 mcg/kg and 
atracurium 0.5 mg/kg were administrated. During 
surgery, continuous ketamine 10 mcg/kg/min was 
given via syringe pump, and propofol TCI concen-
tration is set to maintain bispectral index (BIS) 
value of 50-60. IL-6 blood test was again conducted 
24 hours after the surgery. 
Management of postoperative pain using 
patient-controlled analgesia (PCA) morphine 
(demand dose of 1 mg, lockout interval at 4 minutes, 
and the maximum dose for 4 hours is set at 10 mg). 
The consumption of PCA and pain assessment 
were measured every 4 hours using VAS (visual 
analog scale). IL-6 level tests were examined using 
enzyme-linked immunosorbent assay (ELISA). 
As in C group, all treatments were similar to T 
group, except for the administration of  pre-operative 
clonidine and intra-operative ketamine. No drop-
outs were found in this study. Statistical analysis 
was calculated using SPSS 16.0 for Windows. 
RESULTS 
Subject characteristics are shown in Table 1. There 
are no differences in the characteristics of age, 
body mass index (BMI), and physical status ASA in 
both groups. The mean age in group T and C were 
46.5 and 46.8 years, respectively. The mean BMI was 
22.3 kg/m2 in group T and 22.5 kg/m2 in group C.
Increased levels of IL-6 is calculated based on 
the difference in the levels of IL-6 post and preoper-
atively. The difference of IL-6 level increase between 
the two groups was not statistically significant.
Systolic blood pressure (SBP), mean arterial 
pressure (MAP), and heart rate (HR) in both groups 
were measured at 5 minutes after incision, and then 
recorded again at minutes 15, 30, 60, and 120. Data 
is displayed in the mean ± standard deviation (SD) 
at each measurement time in Table 3, Table 4, and 
Table 5.
Table 1  Characteristics of study subjects by treatment group
Characteristics
Treatment Group
p-value
Group T
(n = 20)
Group C
(n = 20)
Age (years) 46.5 ± 9.0 46.8 ± 10.7 0.937
BMI (kg/m2) 22.3 ± 1.9 22.5 ± 2.2 0.726
ASA*
I 10 (50%) 9 (45%) 0.100
II 10 (50%) 11 (55%)
*ASA = American Society of Anesthesiology physical status
Table 2  Comparison of IL-6 by treatment group (pg/mL)
Characteristic
Treatment Group
p-value
Group T
(n = 20)
Group C
(n = 20)
Preoperative IL-6 18.0 (2.0-99.8) 23,1 (11.3-64.3) 0.387a
Postoperative IL-6 36.6 (10.4-119.4) 38.6 (12.7-193.6) 0.310a
Increase of IL-6 13.6 (0.2-57.0) 16.6 (0.3-173.9) 0.588a
Data shown in mean ± SD or median (minimum-maximum), aMann-Whitney U test
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Postoperative pain was measured using VAS on 
the 4th, 8th, 12th, and 24th hours postoperative. Data 
related to VAS in our study is displayed in mean±SD 
as seen in Table 6. Total consumption of morphine 
in both treatment groups was calculated based on 
the total consumption of morphine recorded by 
PCA. Data is presented in the form of mean±SD in 
Table 7.
Table 3  Comparison of SBP at each measurement time by treatment group
Characteristic
Groups
Mean 
Difference CI95 p-value of
Group T
(n = 20)
Group C
(n = 20)
5 minutes 117.7 ± 13.6 116.9 ± 19.1 0.7 11.4 - 9.8 <0.001a
15 minutes 118.7 ± 13.6 115.7 ± 17.9 3 13.2 - 7.2 <0.001a
30 minutes 115.7 ± 15.6 125.5 ± 18 , 3 9.8 1.1 - 20.7 <0.001a
60 minutes 117.0 ± 12.9 125.3 ± 13.3 8.3 0.13 - 16.7 <0.001a
120 minutes 117.3 ± 13.5 118.8 ± 13.8 1.5 7.3 - 10.2 <0.001a
CI 95% = 95% confidence interval, aunpaired t test
Table 4  Comparison of MAP at each measurement time by treatment group
Characteristic
Groups
Mean 
Difference CI95 p-value
Group T
(n = 20)
Group C
(n = 20)
5 minutes 84.6 ± 9.3 87.9 ± 10.7 3.3 3.1 to 9.7 <0.001a
15 minutes to 87.6 ± 13.5 to 87.8 ± 13.3 0.1 8.5 to 8.6 <0.001a
30 minutes to 86.5 ± 11.3 95.3 ± 15 , 2 8.8 0.2 to 17 , 3 <0.001a
60 minutes 87.7 ± 9.9 93.5 ±to 10.2 5.8 0.6 to 12.2 <0.001a
120 minutes to 86.9 ± 10.0 89.4± 10.7 2.5 4.1 to 9.1 <0.001a
CI95% = 95% confidence interval, aunpaired t test
Table 5  Comparison of HR at each measurement time by treatment group
Characteristic
Groups
Mean 
Difference CI95 p-value
Group T
(n = 20)
Group C
(n = 20)
5 minutes 74.5 ± 11.4 72.0 ± 12.3 2.4 10.0 to 5.1 <0.001a
15 minutes 75.9 ± 9.5 72.3 12.6 3.5 10.7 to 3.6 <0.001a
30 minutes 75.4 ± 8.9 72, 3 ± 10.6 3.1 9 3 to 3.1 <0.001a
60 minutes 73.5 ± 9.6 72.8 ± 9.6 0.6 6.8 to 5.5 <0.001a
120 minutes 72.0 ± 11.5 70.4 ± 8.6 1.6 8.1 to 4.9 <0.001a
CI 95% = 95% confidence interval, aunpaired t test
Table 6  Comparison of VAS (in cm) at each measurement time by treatment group
Hours after 
surgery
Treatment Group
Mean 
Difference 95% CI p-value
Group T
(n = 20)
Group C
( n = 20)
4 hours 2.5 ± 0.9 4.5 ± 1.0 1.9 1.3 to 2.6 <0.001a
8 hours 2.3 ± 0.9 3.9 ± 0.7 1.6 1.1 to 2.2 <0.001a
12 hours 1.6 ± 0.6 3.2 ± 0.9 1.5 1.0 to 2, 0 <0.001a
24 hours 1.3 ± 0.4 1.9 ± 0.6 0.6 0.3 to 1.0 <0.001a
CI95 = 95% confidence interval, aunpaired t test
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DISCUSSION
Effects of anesthesia on cytokines will vary depend-
ing on the drug used and patient’s response. 
Anesthesia with propofol may inhibit and reduce 
the effects of pro-inflammatory cytokines IL-6 
compared to volatile inhalational agents. Ketamine 
is said to increase the production of IL-6. 
Clonidine is a selective partial alpha-2 agonist 
previously used as antihypertensive drugs to lower 
the sympathetic response of the central nervous 
system (CNS). Other known effects of clonidine 
include sedation, analgesia, antianxiety, reducing the 
anesthetic dose, and providing perioperative hemo-
dynamic stability. While ketamine has sympathomi-
metic effects like increased blood pressure, heart rate, 
cardiac contractility, cardiac output and systemic 
vascular resistance. Clonidine and ketamine have 
inversely proportional different effects. By combin-
ing both drugs, we can expect effects of sedation, 
analgesia, and hemodynamic stability.
In this study, levels of IL-6 did not differ signifi-
cantly (p >0.05) between the two groups. Propofol 
has been found to inhibit IL-6 production.5 While 
clonidine reduces central nervous system sympa-
thetic activity, which in turn reduce the neuroendo-
crine stress response that arises through activation 
of the autonomic nervous system. In general, the 
effects of ketamine itself is different with propofol 
and clonidine which is a sympathomimetic and the 
effect can increase the production of IL-6.6
We also compared changes in SBP, MAP, and HR 
at each set time of measurement. One effect of clon-
idine is hemodynamic stability and can be achieved 
in this study. By lowering the intraoperative sympa-
thetic response, clonidine can retain SBP, MAP, and 
HR without too many changes. 
Clonidine at supra-spinal level affects the nucleus 
in the brainstem, activating the alpha-2 postsynaptic 
adrenoreceptor and activating noradrenergic imid-
azole bond in the lateral reticular nucleus resulting 
in a reduction in sympathetic tone. In the peripheral 
level, it affects the presynaptic alpha-2 adrenorecep-
tor reducing the release of norepinephrine in the 
sympathetic nerve terminals, causing dilation of 
blood vessels and reduces the chronotropic effect on 
the heart. These supra-spinal and peripheral effects 
are contrary to the effects of peripheral vasocon-
striction due to direct stimulation of the receptor 
alpha-2 and alpha-1 of clonidine.6,7
Ketamine is an intravenous anesthetic drug that 
can increase blood pressure, heart rate, cardiac 
contractility, cardiac output and systemic vascular 
Table 7  Comparison of total morphine consumption by treatment group
Characteristic
Groups
p-value
Group T
(n = 20)
Group C
(n = 20)
Total consumption of 
morphine (mg)
3.6 ± 1.5 9.9 ± 3.3 <0.001b
bMann-Whitney U test
Figure 1  Comparison of mean SBP at each 
measurement time by treatment group
Figure 2  Comparison of the mean MAP at each 
measurement time by treatment group
Figure 3  Comparison of mean heart rate at each 
measurement time by treatment group
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resistance. It is an indirect effect due to increased 
central sympathetic tone and increased central 
catecholamine from the adrenal medulla. 
The increase in SBP in adults who received 
the clinical dose of ketamine ranging from 20-40 
mmHg, with a slight increase in diastolic blood 
pressure. Systemic blood pressure usually rises 
progressively during the first 3-5 minutes after 
intravenous injection of ketamine, then declined 
over the next 10-90 minutes.8 
The combined effect of clonidine and ketamine 
are expected to results in the balance of effects that 
decrease sympathetic of clonidine and ketamine 
that stimulates the sympathetic response. 
All subjects received post-operative analgesia 
using PCA morphine with PCA dose of 1 mg, 
lock-out intervals of 6 minutes, and the maximum 
dose of 10 mg/4 hours. VAS scores were statistically 
different at each measurement time (p <0.05).
Clonidine as an alpha-2 agonist has an analgesic 
effect. Clonidine regulates peripheral anti-nocicep-
tive, supra-spinal, and especially spinal cord mecha-
nisms that include alpha-2 receptor activation from 
descending postsynaptic noradrenergic, cholinergic 
neurons and the release of nitric oxide pathways.9 
Intravenous clonidine can penetrate the brain’s 
nerve cell so that it can provide analgesia with 
local neuroaxial and supra-spinal. Analgesia at 
Peripheral level occurs by way of debilitating pain 
nerve stimulation of A delta and C fibers and blocks 
conduction through increased potassium conduc-
tance.9 If administered intravenously, slow elimi-
nation will occur within 2 to 24 hours. VAS scores 
were lower in the combination propofol TCI could 
occur due to the effects of clonidine.
Ketamine is a non-competitive NMDA recep-
tor antagonist with a strong analgesic effect. For 
sedation and analgesia, ketamine administered at a 
sub-anesthetic dose of 0.2 to 0.75 mg/kg intravenous 
continuous infusion of 5-20 mcg/kg/min, intramus-
cular 2-4 mg/kg. Analgesia by ketamine achieved 
in plasma concentrations of 100-150 pg/ml.7 This 
dose is sufficient to achieve plasma concentrations 
of 100-150 ng/ml. Ketamine dose of 50 µg/kg did 
not provide sufficient analgesia, but enough to make 
the drowsiness. These plasma concentrations can 
be achieved by continuous infusion at a dose of 
3-4 µg/ kg/min after the initial bolus and 14 µg/kg/
min without an initial dose.10
The combination of clonidine and ketamine has 
a synergistic effect in postoperative analgesia so 
VAS score in the group T receiving both drugs was 
lower. Morphine consumption is calculated by look-
ing at the total consumption of morphine recorded 
in the PCA machine. The mean consumption of 
morphine per 24-hour on group T is 3.6±1.5 mg, 
which is lower compared with the placebo group 
(9.9 ± 3.3 mg) and statistically significant (p <0.05). 
These results are consistent with postoperative VAS 
score between the two groups. 
CONCLUSION
TIVA using TCI propofol combined with preop-
erative clonidine and intraoperative ketamine is 
effective in maintaining hemodynamic stability, 
reducing post-operative, and reducing morphine 
consumption compared to TCI propofol alone. 
However, this study did not prove that it can also 
suppress pro-inflammatory cytokines IL-6 level.
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